tiprankstipranks
Trending News
More News >
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market
Advertisement

Avidity Biosciences (RNA) Stock Statistics & Valuation Metrics

Compare
1,050 Followers

Total Valuation

Avidity Biosciences has a market cap or net worth of $6.05B. The enterprise value is $2.50B.
Market Cap$6.05B
Enterprise Value$2.50B

Share Statistics

Avidity Biosciences has 128,653,340 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding128,653,340
Owned by Insiders1.35%
Owned by Institutions32.82%

Financial Efficiency

Avidity Biosciences’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -25.78%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-25.78%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee27.87K
Profits Per Employee-824.30K
Employee Count391
Asset Turnover<0.01
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Avidity Biosciences is ―. Avidity Biosciences’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value2.28
Price to FCF
Price to Operating Cash Flow-12.21
PEG Ratio

Income Statement

In the last 12 months, Avidity Biosciences had revenue of 10.90M and earned -322.30M in profits. Earnings per share was -2.89.
Revenue10.90M
Gross Profit10.90M
Operating Income-378.94M
Pretax Income-322.30M
Net Income-322.30M
EBITDA-376.16M
Earnings Per Share (EPS)-2.89

Cash Flow

In the last 12 months, operating cash flow was -489.98M and capital expenditures -12.72M, giving a free cash flow of -502.70M billion.
Operating Cash Flow-489.98M
Free Cash Flow-502.70M
Free Cash Flow per Share-3.91

Dividends & Yields

Avidity Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.88
52-Week Price Change9.60%
50-Day Moving Average36.67
200-Day Moving Average33.59
Relative Strength Index (RSI)69.15
Average Volume (3m)3.32M

Important Dates

Avidity Biosciences upcoming earnings date is Nov 11, 2025, After Close (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend Date

Financial Position

Avidity Biosciences as a current ratio of 15.73, with Debt / Equity ratio of 0.43%
Current Ratio15.73
Quick Ratio15.73
Debt to Market Cap0.00
Net Debt to EBITDA0.57
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Avidity Biosciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Avidity Biosciences EV to EBITDA ratio is -8.06, with an EV/FCF ratio of -9.85.
EV to Sales278.22
EV to EBITDA-8.06
EV to Free Cash Flow-9.85
EV to Operating Cash Flow-10.08

Balance Sheet

Avidity Biosciences has $1.18B in cash and marketable securities with $5.13M in debt, giving a net cash position of -$1.18B billion.
Cash & Marketable Securities$1.18B
Total Debt$5.13M
Net Cash-$1.18B
Net Cash Per Share-$9.16
Tangible Book Value Per Share$12.77

Margins

Gross margin is 92.41%, with operating margin of -3477.43%, and net profit margin of -2957.71%.
Gross Margin92.41%
Operating Margin-3477.43%
Pretax Margin-2957.71%
Net Profit Margin-2957.71%
EBITDA Margin-3451.96%
EBIT Margin-3477.43%

Analyst Forecast

The average price target for Avidity Biosciences is $67.82, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$67.82
Price Target Upside41.82% Upside
Analyst ConsensusStrong Buy
Analyst Count18
Revenue Growth Forecast1.23%
EPS Growth Forecast-20.45%

Scores

Smart Score7
AI Score63
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis